|
Drug IP Protection Could See Boost Under Bill to Speed Rare Disease Treatments
Manufacturer and patient groups are urging Congress to pass the MODDERN Cures Act, which would increase possible financial rewards for companies developing treatments for rare conditions.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives